Mr. Albert Ros served as Executive Vice President of Sales & Marketing - Prescription Medicines Business at Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim GmbH since January 2009. Mr. Ros has been Executive Vice President of Sales & Marketing - Prescription Medicines at Boehringer Ingelheim, Inc. since February 2009. Mr. Ros leads the U.S. sales and marketing strategy of Boehringer Ingelheim's core brands. He has been with Boehringer Ingelheim for 14 years and served as Head of Boehringer Ingelheim's Corporate Division for Marketing of Prescription Medicines since 2005 and led the development of four global products including Spiriva(R), Flomax(R), Mirapex(R) and Micardis(R). H Mr. Albert Ros served as Executive Vice President of Sales & Marketing - Prescription Medicines Business at Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim GmbH since January 2009. Mr. Ros has been Executive Vice President of Sales & Marketing - Prescription Medicines at Boehringer Ingelheim, Inc. since February 2009. Mr. Ros leads the U.S. sales and marketing strategy of Boehringer Ingelheim's core brands. He has been with Boehringer Ingelheim for 14 years and served as Head of Boehringer Ingelheim's Corporate Division for Marketing of Prescription Medicines since 2005 and led the development of four global products including Spiriva(R), Flomax(R), Mirapex(R) and Micardis(R). H

Business Administration